Article Details
Retrieved on: 2021-06-16 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
KAHR develops smart immune-recruitment cancer drugs that activate a targeted immune response by converting cancer camouflage into beacons for ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here